These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 23356914

  • 1. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.
    Le Quintrec M, Zuber J, Moulin B, Kamar N, Jablonski M, Lionet A, Chatelet V, Mousson C, Mourad G, Bridoux F, Cassuto E, Loirat C, Rondeau E, Delahousse M, Frémeaux-Bacchi V.
    Am J Transplant; 2013 Mar; 13(3):663-75. PubMed ID: 23356914
    [Abstract] [Full Text] [Related]

  • 2. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V, Fakhouri F, Roumenina L, Dragon-Durey MA, Loirat C.
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [Abstract] [Full Text] [Related]

  • 3. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
    Bresin E, Rurali E, Caprioli J, Sanchez-Corral P, Fremeaux-Bacchi V, Rodriguez de Cordoba S, Pinto S, Goodship TH, Alberti M, Ribes D, Valoti E, Remuzzi G, Noris M, European Working Party on Complement Genetics in Renal Diseases.
    J Am Soc Nephrol; 2013 Feb; 24(3):475-86. PubMed ID: 23431077
    [Abstract] [Full Text] [Related]

  • 4. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.
    Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G.
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1844-59. PubMed ID: 20595690
    [Abstract] [Full Text] [Related]

  • 5. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C, Verhave JC, Berger SP, van de Kar NCAJ, Wetzels JFM.
    Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363
    [Abstract] [Full Text] [Related]

  • 6. Atypical hemolytic uremic syndrome.
    Loirat C, Frémeaux-Bacchi V.
    Orphanet J Rare Dis; 2011 Sep 08; 6():60. PubMed ID: 21902819
    [Abstract] [Full Text] [Related]

  • 7. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
    Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJ.
    Hum Mutat; 2010 Jun 08; 31(6):E1445-60. PubMed ID: 20513133
    [Abstract] [Full Text] [Related]

  • 8. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
    Phillips EH, Westwood JP, Brocklebank V, Wong EK, Tellez JO, Marchbank KJ, McGuckin S, Gale DP, Connolly J, Goodship TH, Kavanagh D, Scully MA.
    J Thromb Haemost; 2016 Jan 08; 14(1):175-85. PubMed ID: 26559391
    [Abstract] [Full Text] [Related]

  • 9. Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP.
    Cruzado JM, de Córdoba SR, Melilli E, Bestard O, Rama I, Sánchez-Corral P, López-Trascasa M, Navarro I, Torras J, Gomà M, Grinyó JM.
    Am J Transplant; 2009 Jun 08; 9(6):1477-83. PubMed ID: 19459807
    [Abstract] [Full Text] [Related]

  • 10. Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.
    Alberti M, Valoti E, Piras R, Bresin E, Galbusera M, Tripodo C, Thaiss F, Remuzzi G, Noris M.
    Am J Transplant; 2013 Aug 08; 13(8):2201-6. PubMed ID: 23731345
    [Abstract] [Full Text] [Related]

  • 11. Successful long-term outcome after renal transplantation in a patient with atypical haemolytic uremic syndrome with combined membrane cofactor protein CD46 and complement factor I mutations.
    Pabst WL, Neuhaus TJ, Nef S, Bresin E, Zingg-Schenk A, Spartà G.
    Pediatr Nephrol; 2013 Jul 08; 28(7):1141-4. PubMed ID: 23519521
    [Abstract] [Full Text] [Related]

  • 12. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
    Xie L, Nester CM, Reed AI, Zhang Y, Smith RJ, Thomas CP.
    Transplant Proc; 2012 Dec 08; 44(10):3037-40. PubMed ID: 23195022
    [Abstract] [Full Text] [Related]

  • 13. Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.
    Provaznikova D, Rittich S, Malina M, Seeman T, Marinov I, Riedl M, Hrachovinova I.
    Pediatr Nephrol; 2012 Jan 08; 27(1):73-81. PubMed ID: 21706448
    [Abstract] [Full Text] [Related]

  • 14. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
    Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, Boudailliez B, Bouissou F, Deschenes G, Gie S, Tsimaratos M, Fischbach M, Morin D, Nivet H, Alberti C, Loirat C, French Society of Pediatric Nephrology.
    J Am Soc Nephrol; 2007 Aug 08; 18(8):2392-400. PubMed ID: 17599974
    [Abstract] [Full Text] [Related]

  • 15. Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).
    Westra D, Volokhina E, van der Heijden E, Vos A, Huigen M, Jansen J, van Kaauwen E, van der Velden T, van de Kar N, van den Heuvel L.
    Nephrol Dial Transplant; 2010 Jul 08; 25(7):2195-202. PubMed ID: 20106822
    [Abstract] [Full Text] [Related]

  • 16. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.
    Szarvas N, Szilágyi Á, Csuka D, Takács B, Rusai K, Müller T, Arbeiter K, Réti M, Haris Á, Wagner L, Török S, Kelen K, Szabó AJ, Reusz GS, Morgan BP, Prohászka Z.
    Mol Immunol; 2016 Mar 08; 71():10-22. PubMed ID: 26826462
    [Abstract] [Full Text] [Related]

  • 17. Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics.
    Geerdink LM, Westra D, van Wijk JA, Dorresteijn EM, Lilien MR, Davin JC, Kömhoff M, Van Hoeck K, van der Vlugt A, van den Heuvel LP, van de Kar NC.
    Pediatr Nephrol; 2012 Aug 08; 27(8):1283-91. PubMed ID: 22410797
    [Abstract] [Full Text] [Related]

  • 18. Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation.
    Le Quintrec M, Lionet A, Kamar N, Karras A, Barbier S, Buchler M, Fakhouri F, Provost F, Fridman WH, Thervet E, Legendre C, Zuber J, Frémeaux-Bacchi V.
    Am J Transplant; 2008 Aug 08; 8(8):1694-701. PubMed ID: 18557729
    [Abstract] [Full Text] [Related]

  • 19. Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation.
    Fakhouri F, Fila M, Provôt F, Delmas Y, Barbet C, Châtelet V, Rafat C, Cailliez M, Hogan J, Servais A, Karras A, Makdassi R, Louillet F, Coindre JP, Rondeau E, Loirat C, Frémeaux-Bacchi V.
    Clin J Am Soc Nephrol; 2017 Jan 06; 12(1):50-59. PubMed ID: 27799617
    [Abstract] [Full Text] [Related]

  • 20. Rapid recovery of membrane cofactor protein (MCP; CD46) associated atypical haemolytic uraemic syndrome with plasma exchange.
    Reid VL, Mullan A, Erwig LP.
    BMJ Case Rep; 2013 Sep 04; 2013():. PubMed ID: 24005975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.